NCT03000192 HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life Status UNKNOWN Phase N/A
NCT02988817 Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT02984423 FLABRA: Frontline Approach for BRCA Testing in OC Treatment naïve Population. A LATIN AMERICA Epidemiologic Study Status COMPLETED Phase N/A
NCT02978222 Folate Receptor Alpha Peptide Vaccine With GM-CSF Versus GM-CSF Alone in Patients With Platinum Sensitive Ovarian Cancer Status TERMINATED Phase PHASE2
NCT02973750 Determinants of Age-Related Treatment Effectiveness in Ovarian Cancer Status COMPLETED Phase N/A
NCT02970786 Phase I Trial: 68Ga-NODAGA-E(c[RGDyK])2 Positron Emission Tomography for Imaging Angiogenesis in Primary and Metastatic Tumor Lesions in Humans Status UNKNOWN Phase PHASE1
NCT02963831 A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies Status COMPLETED Phase PHASE1/PHASE2
NCT02960594 hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse Status COMPLETED Phase PHASE1
NCT02952183 Efficacy of Pelvic Autonomic Nerve Monitoring System (PAMS I) in Female Patients With Pelvic Tumors Status UNKNOWN Phase NA
NCT02948426 Intraperitoneal Infusion of Autologous Monocytes With Sylatron (Peginterferon Alfa-2b) and Actimmune (Interferon Gamma-1b) in Women With Recurrent or Refractory Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer Status TERMINATED Phase PHASE1
NCT02948075 Safety and Efficacy of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy Status COMPLETED Phase PHASE2
NCT02933073 Study of Oncoimmunome for the Treatment of Stage III/IV Ovarian Carcinoma Status TERMINATED Phase PHASE1
NCT02928549 Factors Associated With the Use of a High Volume Cancer Center by Black Women With Ovarian Cancer: A Qualitative Study Status COMPLETED Phase N/A
NCT02917798 Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient Outcomes Status ACTIVE_NOT_RECRUITING Phase N/A
NCT02916875 Individual Survivorship Program for Ovarian Cancer Patients Based on PROM's and Shared Decision Making Status COMPLETED Phase N/A
NCT02910622 Pilot Study Evaluating the Oncogramme: Analysis of Response to Induction Treatment of Patients With Breast or Ovarian Cancer. Status COMPLETED Phase N/A
NCT02897375 Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02891824 ATALANTE: Atezolizumab vs Placebo Phase III Study in Late Relapse Ovarian Cancer Treated With Chemotherapy+Bevacizumab Status COMPLETED Phase PHASE3
NCT02884648 Bevacizumab in Ovarian Cancer Patients With Disease at Second-Look Surgery Status ACTIVE_NOT_RECRUITING Phase PHASE2